Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1985 3
1986 1
1987 1
1988 1
1989 1
1991 2
1993 2
1998 2
1999 1
2001 1
2002 1
2004 1
2006 1
2007 1
2008 2
2010 1
2011 2
2012 2
2015 2
2016 4
2017 1
2018 2
2019 3
2020 10
2021 23
2022 10
2023 8
2024 7
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

74 results

Results by year

Filters applied: . Clear all
Page 1
The genetics of kidney stone disease and nephrocalcinosis.
Singh P, Harris PC, Sas DJ, Lieske JC. Singh P, et al. Among authors: sas dj. Nat Rev Nephrol. 2022 Apr;18(4):224-240. doi: 10.1038/s41581-021-00513-4. Epub 2021 Dec 14. Nat Rev Nephrol. 2022. PMID: 34907378 Review.
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1.
Garrelfs SF, Frishberg Y, Hulton SA, Koren MJ, O'Riordan WD, Cochat P, Deschênes G, Shasha-Lavsky H, Saland JM, Van't Hoff WG, Fuster DG, Magen D, Moochhala SH, Schalk G, Simkova E, Groothoff JW, Sas DJ, Meliambro KA, Lu J, Sweetser MT, Garg PP, Vaishnaw AK, Gansner JM, McGregor TL, Lieske JC; ILLUMINATE-A Collaborators. Garrelfs SF, et al. Among authors: sas dj. N Engl J Med. 2021 Apr 1;384(13):1216-1226. doi: 10.1056/NEJMoa2021712. N Engl J Med. 2021. PMID: 33789010 Clinical Trial.
Comprehensive Genetic Analysis Reveals Complexity of Monogenic Urinary Stone Disease.
Cogal AG, Arroyo J, Shah RJ, Reese KJ, Walton BN, Reynolds LM, Kennedy GN, Seide BM, Senum SR, Baum M, Erickson SB, Jagadeesh S, Soliman NA, Goldfarb DS, Beara-Lasic L, Edvardsson VO, Palsson R, Milliner DS, Sas DJ, Lieske JC, Harris PC; Investigators of the Rare Kidney Stone Consortium. Cogal AG, et al. Among authors: sas dj. Kidney Int Rep. 2021 Sep 8;6(11):2862-2884. doi: 10.1016/j.ekir.2021.08.033. eCollection 2021 Nov. Kidney Int Rep. 2021. PMID: 34805638 Free PMC article.
Diagnosis and management of primary hyperoxalurias: best practices.
Michael M, Harvey E, Milliner DS, Frishberg Y, Sas DJ, Calle J, Copelovitch L, Penniston KL, Saland J, Somers MJG, Baum MA. Michael M, et al. Among authors: sas dj. Pediatr Nephrol. 2024 Nov;39(11):3143-3155. doi: 10.1007/s00467-024-06328-2. Epub 2024 May 16. Pediatr Nephrol. 2024. PMID: 38753085 Review.
Primary Hyperoxaluria Type 1.
Milliner DS, Harris PC, Sas DJ, Cogal AG, Lieske JC. Milliner DS, et al. Among authors: sas dj. 2002 Jun 19 [updated 2024 Aug 15]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. 2002 Jun 19 [updated 2024 Aug 15]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. PMID: 20301460 Free Books & Documents. Review.
Primary Hyperoxaluria Type 3.
Milliner DS, Harris PC, Sas DJ, Lieske JC. Milliner DS, et al. Among authors: sas dj. 2015 Sep 24 [updated 2023 Feb 9]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. 2015 Sep 24 [updated 2023 Feb 9]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. PMID: 26401545 Free Books & Documents. Review.
Editorial Comment.
Sas DJ. Sas DJ. J Urol. 2021 Apr;205(4):1187. doi: 10.1097/JU.0000000000001411.01. Epub 2021 Jan 22. J Urol. 2021. PMID: 33481651 No abstract available.
Efficacy and safety of lumasiran for infants and young children with primary hyperoxaluria type 1: 12-month analysis of the phase 3 ILLUMINATE-B trial.
Hayes W, Sas DJ, Magen D, Shasha-Lavsky H, Michael M, Sellier-Leclerc AL, Hogan J, Ngo T, Sweetser MT, Gansner JM, McGregor TL, Frishberg Y. Hayes W, et al. Among authors: sas dj. Pediatr Nephrol. 2023 Apr;38(4):1075-1086. doi: 10.1007/s00467-022-05684-1. Epub 2022 Aug 1. Pediatr Nephrol. 2023. PMID: 35913563 Free PMC article. Clinical Trial.
74 results